Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8824 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8776 |
High Similarity |
NPD1653 |
Approved |
0.875 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8705 |
High Similarity |
NPD1613 |
Approved |
0.8705 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD2801 |
Approved |
0.8489 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8444 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8421 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8258 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8194 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8146 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8129 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8026 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.8015 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7902 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7901 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7877 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7801 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7736 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7635 |
Intermediate Similarity |
NPD447 |
Suspended |
0.763 |
Intermediate Similarity |
NPD228 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD37 |
Approved |
0.7603 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7566 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7552 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7548 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7531 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD919 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7451 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7445 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD1611 |
Approved |
0.741 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7389 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7329 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7329 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7325 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.729 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD943 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7186 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1091 |
Approved |
0.717 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5762 |
Approved |
0.716 |
Intermediate Similarity |
NPD4678 |
Approved |
0.716 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7132 |
Intermediate Similarity |
NPD968 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7091 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7081 |
Intermediate Similarity |
NPD920 |
Approved |
0.7076 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7034 |
Intermediate Similarity |
NPD17 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7029 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7027 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7011 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7 |
Intermediate Similarity |
NPD5242 |
Approved |
0.6994 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6994 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD4140 |
Approved |
0.6989 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6989
|
Remote Similarity |
NPD8054 |
Approved |